FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

4 results

brilinta
(Ticagrelor)
AstraZeneca Pharmaceuticals LP
Usage: BRILINTA is indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction, as well as for those with high-risk coronary artery disease. It also decreases stroke risk in patients with acute ischemic stroke or transient ischemic attack.
ticagrelor
(ticagrelor)
Solco Healthcare U.S., LLC
Usage: Ticagrelor is indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. It also lowers the risk of stent thrombosis and is used to reduce stroke risk in acute ischemic stroke and high-risk transient ischemic attack patients.
ticagrelor
(ticagrelor)
Amneal Pharmaceuticals NY LLC
Usage: Ticagrelor tablets are indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. They also prevent stent thrombosis and reduce the risk of first myocardial infarction or stroke in high-risk coronary artery disease patients.
ticagrelor
(TICAGRELOR)
AvKARE
Usage: Ticagrelor tablets are indicated for reducing the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction. It also helps prevent first myocardial infarctions or strokes in high-risk patients with coronary artery disease and reduces stroke risk in acute ischemic stroke or high-risk TIA patients.

Medications for Transient Ischemic Attack

brilinta

ticagrelor

ticagrelor

ticagrelor